GL1X · GenesisL1 explorer

MolNFT v1 · #103387 · protein

Crystal structure of insulin degrading enzyme complexed with inhibitor

4PF9 · Insulin-degrading enzyme: “Crystal structure of insulin degrading enzyme complexed with inhibitor”. X-ray diffraction, 2 ligands (2Q6, ZN), 20 pockets (best druggability 0.83). MolNFT v1 #103387 on GenesisL1: 3D structure, binding…

PDB
4PF9
Type
protein
Length
1,915 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin-degrading enzyme
EC
3.4.24.56
UniProt
P14735
Ligands
2Q6, ZN
Pockets
20 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInsulin-degrading enzyme (EC 3.4.24.56)protein95943% helix, 20% strandP14735
BInsulin-degrading enzyme (EC 3.4.24.56)protein95643% helix, 20% strandP14735

Ligands and binding sites

  • 2Q6 · methyl [(2S)-2-[4-({5-[4-({(2S)-2-[(3S)-3-amino-2-oxopiperidin-1-yl]-2-cyclohexylacetyl}amino)phenyl]pentyl}oxy)phenyl]-3-(quinolin-3-yl)propyl]carbamate · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 14 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110890.830.84117empty
29500.750.781072Q6
310000.740.7782empty
48380.710.7678empty
53350.710.8451empty

Interfaces

1 interface between chains.

  • A–B · 1564 Ų buried · 17 hydrogen bonds · protein-protein

Compared structures

  • 4PF9 · Crystal structure of insulin degrading enzyme complexed with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.